Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study

被引：0
|
作者：
Breen, K. [1 ,2 ,3 ]
McCormack, J. [2 ,3 ]
Fabre, A. [1 ,2 ,3 ]
机构：
[1] St Vincents Univ Hosp, Dept Histopathol, Dublin 4, Ireland
[2] UCD, Conway Inst, Res Pathol Core Facil, Dublin 4, Ireland
[3] UCD Sch Med, Dublin 4, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2017年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5.10
引用
收藏
页码：S417 / S418
页数：2
相关论文
共 50 条
  • [1] Screening for PD-L1 expression by immunohistochemistry in non-small cell lung cancer (NSCLC) in the era of immunotherapy: a national study
    Breen, K.
    McCormack, J.
    Fabre, A.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (SUPPL 10) : S417 - S418
  • [2] Assessment of PD-L1 expression by immunohistochemistry in histological and cytological non-small cell lung carcinoma (NSCLC) in the era of immunotherapy: A national Irish study
    Fabre, A.
    Breen, K.
    Mccormack, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S2 - S3
  • [3] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [4] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [5] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [6] Current PD-L1 immunohistochemistry for non-small cell lung cancer
    Scheel, Andreas H.
    Schaefer, Stephan C.
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (03) : 1217 - 1219
  • [7] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
  • [8] Multicentre study on the consistency of PD-L1 immunohistochemistry as predictive test for immunotherapy in non-small cell lung cancer
    Butter, Rogier
    't Hart, Nils A.
    Hooijer, Gerrit K. J.
    Monkhorst, Kim
    Speel, Ernst-Jan
    Theunissen, Paul
    Thunnissen, Erik
    Von der Thusen, Jan H.
    Timens, Wim
    van de Vijver, Marc J.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2020, 73 (07) : 423 - 430
  • [9] Anti-PD-1/PD-L1 antibodies in non-small cell lung cancer: the era of immunotherapy
    Valecha, Gautam Kishore
    Vennepureddy, Adarsh
    Ibrahim, Uroosa
    Safa, Firas
    Samra, Bachar
    Atallah, Jean Paul
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (01) : 47 - 59
  • [10] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    [J]. LUNG CANCER, 2020, 147 : 91 - 98
12345